Literature DB >> 26177086

Protection Against Cold Storage-Induced Renal Tubular Cell Apoptosis.

Swati Jain1, Daniel Keys, Danica Ljubanovic, Charles L Edelstein, Alkesh Jani.   

Abstract

BACKGROUND: Prolonged cold storage (CS) of donor kidneys is associated with tubular cell apoptosis and caspase-3 activation. We have previously shown that pancaspase inhibition prevents CS-associated tubular apoptosis. Because of the nonspecific nature of pancaspase inhibitors, which block all caspases including proinflammatory caspase-1, the effect of specific caspase-3 inhibition during CS is unknown. X-linked inhibitor of apoptosis (XIAP) is the most potent naturally occurring specific inhibitor of caspase-3. We hypothesized that prolonged CS would decrease XIAP, whereas upregulation of XIAP with the novel compound UCF-101 would protect against caspase-3 activation and tubular cell apoptosis.
METHODS: LLC-PK1 tubular cells and whole kidneys from C57BL/6 mice were subjected to prolonged CS with or without UCF-101, and examined for XIAP, caspase-3, and tubular apoptosis.
RESULTS: Tubular cells subjected to prolonged CS in vitro demonstrated significantly decreased XIAP and significantly increased apoptosis, caspase-3 protein and activity. UCF-101 treatment significantly increased XIAP, significantly decreased capsase-3 protein and activity, and protected against apoptosis. To determine the therapeutic significance, whole kidneys were subjected to prolonged CS with UCF-101. UCF-101 significantly increased XIAP in donor kidneys and protected against apoptosis.
CONCLUSIONS: Prolonged CS of tubular cells in vitro and whole mouse kidneys ex vivo is associated with loss of XIAP and subsequent tubular cell apoptosis. UCF-101 protects against the loss of XIAP during prolonged CS both in vitro and ex vivo, and is associated with significantly reduced tubular cell apoptosis. UCF-101 may represent an attractive approach to improve organ preservation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26177086      PMCID: PMC4618769          DOI: 10.1097/TP.0000000000000774

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  28 in total

1.  The serine protease Omi/HtrA2 is involved in XIAP cleavage and in neuronal cell death following focal cerebral ischemia/reperfusion.

Authors:  J Althaus; M D Siegelin; F Dehghani; L Cilenti; A S Zervos; A Rami
Journal:  Neurochem Int       Date:  2006-09-15       Impact factor: 3.921

2.  Broad-spectrum caspase inhibitors: from myth to reality?

Authors:  D Chauvier; S Ankri; C Charriaut-Marlangue; R Casimir; E Jacotot
Journal:  Cell Death Differ       Date:  2006-09-29       Impact factor: 15.828

3.  Role of Omi/HtrA2 in apoptotic cell death after myocardial ischemia and reperfusion.

Authors:  Hui-Rong Liu; Erhe Gao; Aihua Hu; Ling Tao; Yan Qu; Patrick Most; Walter J Koch; Theodore A Christopher; Bernard L Lopez; Emad S Alnemri; Antonis S Zervos; Xin L Ma
Journal:  Circulation       Date:  2004-12-20       Impact factor: 29.690

4.  Perfusion storage reduces apoptosis in a porcine kidney model of donation after cardiac death.

Authors:  Alkesh Jani; Michael Zimmerman; Jessica Martin; Li Lu; Kultigin Turkmen; Kameswaran Ravichandran; Arijana Pacic; Danica Ljubanović; Charles L Edelstein
Journal:  Transplantation       Date:  2011-01-27       Impact factor: 4.939

5.  DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis.

Authors:  X Liu; H Zou; C Slaughter; X Wang
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

Review 6.  Inhibitor of apoptosis (IAP) proteins in regulation of inflammation and innate immunity.

Authors:  Rune B Damgaard; Mads Gyrd-Hansen
Journal:  Discov Med       Date:  2011-03       Impact factor: 2.970

7.  Omi/HtrA2 protease is associated with tubular cell apoptosis and fibrosis induced by unilateral ureteral obstruction.

Authors:  Jinu Kim; Dong Sun Kim; Mae Ja Park; Hee-Jung Cho; Antonis S Zervos; Joseph V Bonventre; Kwon Moo Park
Journal:  Am J Physiol Renal Physiol       Date:  2010-03-10

Review 8.  Caspases as drug targets in ischemic organ injury.

Authors:  S Faubel; C L Edelstein
Journal:  Curr Drug Targets Immune Endocr Metabol Disord       Date:  2005-09

9.  HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins.

Authors:  Anne M Verhagen; John Silke; Paul G Ekert; Miha Pakusch; Hitto Kaufmann; Lisa M Connolly; Catherine L Day; Anjali Tikoo; Richard Burke; Carolyn Wrobel; Robert L Moritz; Richard J Simpson; David L Vaux
Journal:  J Biol Chem       Date:  2001-10-16       Impact factor: 5.157

10.  UCF-101, a novel Omi/HtrA2 inhibitor, protects against cerebral ischemia/reperfusion injury in rats.

Authors:  Danying Su; Zhiqiang Su; Jiaye Wang; Shanshan Yang; Jing Ma
Journal:  Anat Rec (Hoboken)       Date:  2009-06       Impact factor: 2.064

View more
  1 in total

1.  Deletion of TLR4 reduces apoptosis and improves histology in a murine kidney transplant model.

Authors:  Swati Jain; Robert Plenter; Trevor Nydam; Ronald G Gill; Alkesh Jani
Journal:  Sci Rep       Date:  2021-08-10       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.